Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 30 studies | 25% ± 10% | |
epithelial cell | 13 studies | 34% ± 20% | |
fibroblast | 11 studies | 23% ± 9% | |
endothelial cell of lymphatic vessel | 9 studies | 26% ± 8% | |
type I pneumocyte | 8 studies | 25% ± 9% | |
ciliated cell | 8 studies | 32% ± 9% | |
capillary endothelial cell | 8 studies | 23% ± 4% | |
macrophage | 8 studies | 19% ± 3% | |
oligodendrocyte | 8 studies | 25% ± 7% | |
smooth muscle cell | 7 studies | 19% ± 4% | |
respiratory goblet cell | 7 studies | 29% ± 9% | |
secretory cell | 7 studies | 30% ± 13% | |
basal cell | 7 studies | 43% ± 20% | |
club cell | 7 studies | 27% ± 13% | |
endothelial cell of artery | 6 studies | 19% ± 4% | |
vein endothelial cell | 6 studies | 28% ± 13% | |
endothelial cell of vascular tree | 6 studies | 24% ± 10% | |
pericyte | 6 studies | 21% ± 4% | |
natural killer cell | 5 studies | 20% ± 2% | |
type II pneumocyte | 5 studies | 20% ± 3% | |
classical monocyte | 5 studies | 24% ± 8% | |
astrocyte | 5 studies | 32% ± 10% | |
goblet cell | 5 studies | 32% ± 27% | |
squamous epithelial cell | 4 studies | 58% ± 12% | |
mesothelial cell | 4 studies | 19% ± 1% | |
lymphocyte | 4 studies | 28% ± 5% | |
glutamatergic neuron | 4 studies | 43% ± 12% | |
T cell | 3 studies | 27% ± 11% | |
hillock cell | 3 studies | 21% ± 3% | |
non-classical monocyte | 3 studies | 25% ± 10% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 18% ± 1% | |
hematopoietic precursor cell | 3 studies | 25% ± 7% | |
glomerular endothelial cell | 3 studies | 21% ± 4% | |
neuron | 3 studies | 21% ± 8% | |
microglial cell | 3 studies | 20% ± 4% | |
erythroblast | 3 studies | 22% ± 4% | |
CD8-positive, alpha-beta memory T cell | 3 studies | 21% ± 4% | |
GABAergic neuron | 3 studies | 42% ± 3% | |
dendritic cell | 3 studies | 32% ± 14% | |
pancreatic ductal cell | 3 studies | 39% ± 20% | |
interneuron | 3 studies | 43% ± 15% | |
podocyte | 3 studies | 42% ± 12% | |
oligodendrocyte precursor cell | 3 studies | 26% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 10621.18 | 1445 / 1445 | 100% | 68.23 | 183 / 183 |
lung | 100% | 7916.56 | 578 / 578 | 100% | 42.93 | 1154 / 1155 |
bladder | 100% | 7840.81 | 21 / 21 | 100% | 44.47 | 502 / 504 |
prostate | 100% | 5135.28 | 245 / 245 | 100% | 36.55 | 500 / 502 |
breast | 100% | 6601.95 | 459 / 459 | 99% | 47.26 | 1111 / 1118 |
thymus | 100% | 6075.14 | 653 / 653 | 99% | 35.99 | 600 / 605 |
pancreas | 100% | 3007.93 | 327 / 328 | 99% | 50.94 | 177 / 178 |
uterus | 100% | 6945.92 | 170 / 170 | 99% | 45.70 | 454 / 459 |
stomach | 100% | 4433.61 | 359 / 359 | 98% | 41.81 | 279 / 286 |
intestine | 100% | 6829.03 | 966 / 966 | 98% | 37.00 | 514 / 527 |
kidney | 100% | 4520.19 | 89 / 89 | 97% | 36.23 | 878 / 901 |
brain | 99% | 3627.73 | 2623 / 2642 | 97% | 20.67 | 685 / 705 |
adrenal gland | 100% | 4246.52 | 258 / 258 | 93% | 25.84 | 215 / 230 |
skin | 100% | 7330.63 | 1809 / 1809 | 90% | 25.13 | 424 / 472 |
ovary | 100% | 6821.09 | 180 / 180 | 88% | 14.03 | 379 / 430 |
liver | 97% | 1802.62 | 220 / 226 | 85% | 15.16 | 346 / 406 |
adipose | 100% | 6810.45 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 7270.72 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 5086.12 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3526.38 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 51.35 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 30.92 | 1 / 1 |
heart | 98% | 4051.65 | 846 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 79% | 12.48 | 23 / 29 |
peripheral blood | 71% | 2037.01 | 660 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 64% | 12.20 | 51 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0031122 | Biological process | cytoplasmic microtubule organization |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0030334 | Biological process | regulation of cell migration |
GO_0051893 | Biological process | regulation of focal adhesion assembly |
GO_0006915 | Biological process | apoptotic process |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0070062 | Cellular component | extracellular exosome |
GO_0031252 | Cellular component | cell leading edge |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0045296 | Molecular function | cadherin binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SLK |
Protein name | Alternative protein SLK STE20 like kinase STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2) |
Synonyms | KIAA0204 STK2 |
Description | FUNCTION: Mediates apoptosis and actin stress fiber dissolution. . |
Accessions | ENST00000369755.4 [Q9H2G2-1] Q9H2G2 L8ECF1 ENST00000335753.8 [Q9H2G2-2] A0A5F9ZH68 ENST00000672560.1 |